Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

Go back to Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
Novavax, Inc. (NASDAQ: NVAX) Delayed: 174.41 --0 (-0%)
Previous Close $174.41    52 Week High $9.23 
Open $174.41    52 Week Low $1.16 
Day High $174.41    P/E N/A 
Day Low $174.41    EPS $-0.30 
Volume 1,917